Document:

EXHIBIT 4.2 - ADDENDUM #5 TO INVESTMENT AGREEMENT DATED JUNE 13, 2002

                                   ADDENDUM #5
               TO AN AGREEMENT MADE AND ENTERED ON 16 JANUARY 2000

           Made and entered on this 13 day of June 2002, by and among:

ACTIVEPOINT, LTD.
Company No. 51-0255867-7
Poleg Industrial Park, Giborei Israel 20, Netanya, Israel, 42504
(Hereinafter: the "COMPANY")

and

ONN TAVOR
I.D. 056148745
of 10 Bet Shammai St., Ramat Hasharon
(Hereinafter: the "FOUNDER")

and

TOPSCHUTTER HOLDING B.V.
c/o Mr. Jean Paul Croisier, 61 Rue du Rhone
Geneve, Switzerland
(Hereinafter: the "INVESTOR")

WHEREAS, the Parties have previously executed an Agreement dated January 16,
2000 (the "INVESTMENT AGREEMENT"), and an Addendum thereto dated May 28, 2000
(the "FIRST ADDENDUM"), a second Addendum thereto dated February 01, 2001 (the
"SECOND ADDENDUM"), and a third Addendum thereto dated July 29, 2001 (the "THIRD
ADDENDUM"), and a fourth Addendum thereto dated December 10, 2001 (the "FOURTH
ADDENDUM"). The Investment Agreement, and the First, Second, Third and Fourth
Addendums shall be hereinafter referred to jointly as the "AGREEMENT"); and

WHEREAS, the Parties wish to add to and/or amend the provisions of the Agreement
as set forth hereinafter in this fifth addendum (the "ADDENDUM"):

<PAGE>

NOW, THEREFORE, in consideration of the promises, mutual agreements and
covenants set forth below, the Parties agree:

1. Unless the context compels otherwise, the terms used in this Addendum shall
bear the meanings ascribed thereto in the Investment Agreement.

2. The Company and the Founder represent that upon completion of the investment
stipulated under the Fourth Addendum by the Investor and the investment
stipulated under an agreement entitled "ADDENDUM 4A" with SHIR H.Y.E.R.
Holdings, Ltd., and prior to the execution of the transaction stipulated herein,
and further, prior to any additional investment or loan undertaken by the
Investor with the approval of the Founder as detailed herein, the holdings of
the Company's share capital, on a fully diluted basis shall be as listed
hereunder (all Company shares bear a par value of NIS 0.1).
<TABLE>
<CAPTION>

------------------------------------------------------------ --------------------------------------------
NAME OF SHAREHOLDER                                          HOLDINGS
------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
<S>                                                            <C>
a. The Founder 5650 Ordinary Shares
------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
b.  The Investor                                             2750 Ordinary Shares; 8237 Preferred Shares
------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
c.                                                           Target Technology
                                                             Center 1500
                                                             Ordinary Shares
                                                             (out of which 1000
                                                             shares are held in
                                                             trust for Company
                                                             employees, and an
                                                             additional 125
                                                             shares are held in
                                                             trust for Mr.
                                                             Azriel Kadim and
                                                             are to be
                                                             transferred
                                                             thereto)
------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
d. Daniel Eini 250 Ordinary Shares
------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
e. Yitzhak Turkeltaub 250 Ordinary Shares
------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
f.  SHIR H.Y.E.R. Holdings Ltd.                              250 Ordinary Shares; 460 Preferred Shares
------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
g.  Y.E.R.H. Trusts Ltd.                                     159 Ordinary Shares
------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
h.  Dr. Sydney O'Hara                                        381 Ordinary Shares

------------------------------------------------------------ --------------------------------------------
------------------------------------------------------------ --------------------------------------------
i.  Christopher Gare                                         Vested with option to purchase 64 Ordinary
                                                             Shares at par value

                                                             Options to purchase
                                                             an additional 128
                                                             Ordinary Shares in
                                                             the aggregate at
                                                             par value will vest
                                                             in accordance with
                                                             the provisions of
                                                             the Company's
                                                             agreement
                                                             therewith.
------------------------------------------------------------ --------------------------------------------
</TABLE>

                                      -2-
<PAGE>

Besides the foregoing, there are no additional outstanding Company Shares,
options to purchase shares, or other securities of any kind.

3. In addition to the Investor's previous investment sin the Company, the
Investor hereby undertakes to provide a further loan to the Company up to the
amount of $45,000 (the "LOAN") subject to and pursuant with the provisions
hereof. The Loan is intended to be used by the Company to finance the operations
of the Company, and shall be used consistent with a budget to be prepared by the
Company in conjunction with the Investor's representative (notwithstanding the
foregoing, the Company shall have the overriding right to supervise and oversee
the allocation of the Loan funds, to have access thereto, and to determine how
they shall be expended including, inter alia, to determine that a portion of the
funds be utilized for different Company requirements, such as travel
expenditures, etc. subject to the Investor's approval at all times). The
Investor will convey the Loan to the Company monthly, beginning in May 2002,
over a period of three months in equal amounts of $15,000..00 (the "LOAN
INSTALLMENTS") each by way of a bank transfer to the bank account of the Company
in Israel. In the event that the Investor decides to terminate the providing of
the Loan installments he shall be required to provide the Company with a one
month prior written notice to that effect and continue to pay the installments
due be paid hereunder during that one full month period.

                                      -3-
<PAGE>

4. The Company shall issue the Investor a total of 20,998 Preferred Company
Shares at their nominal value (NIS 0.1), which shall be issued thereto in three
installments, subsequent to the commensurate with the execution of each Loan
Installment. Following the execution of the initial Loan Installment the Company
shall issue to the Investor 7,000 Preferred Company Shares, while promptly
following each of the two ensuring Loan Installments the Company shall issue the
Investor 6,999 Preferred Company Shares. Issuance of the shares pursuant to each
of the Loan Installments shall be executed forthwith upon transfer to the
Company of the Loan Installment corresponding to such issuance pursuant to
Clause 3 here above and shall take place not later than fourteen (14) days from
the date of said transfer.

5. In addition to the foregoing, the Investor shall likewise be entitled to
receive the following: Subject to any taxes and mandatory payments imposed on
the Company (such as royalties due to the Israeli chief scientist) 25% of all
amounts, in excess of an initial sum of U.S. $100,000 which is to remain in the
Company up to a total amount equaling the sums of the loans actually extended by
the Investor under this Fifth Addendum and the Fourth Addendum, i.e. up to a
possible total of U.S. $180,000 a sum comprised of the nominal sum of the actual
total of the Loan (i.e. up to a potential total of U.S. $45,000) plus the
nominal sums of the loans actually granted to the Company pursuant to the Fourth
Addendum (i.e. U.S. $135,000), all such sums free of any interest and/or
adjustment of any kind (the "LOAN REPAYMENT"). All such sums accrued on account
of the Loan Repayment shall be transferred to the Investor immediately (within
fourteen (14) working days) upon their actual receipt by the Company. The
Investor shall harbor no claim towards the Founder personally and the Founder
shall have no responsibility or liability whatsoever if the Company fails to
repay any of the loan installments provided by the Investor hereunder. The
provisions of this Section 5 shall replace the provisions of Section 8 of the
Fourth Addendum.

Issuance of the above shares following each of the abovementioned loan
installments shall be executed forthwith upon transfer to the Company of the
relevant loan installment corresponding to such issuance pursuant to Clause 4
here above and shall take place not later than fourteen (14) days from the date
of said transfer.

                                      -4-
<PAGE>

6. Following the execution in full of all installments of the Loan an issuance
of all shares to be issued to all parties mentioned herein, all in accordance
with the terms of this Addendum, the holdings of the Company's share capital on
a fully diluted basis, shall be listed in the "cap table" as "APPENDIX B"
hereto.

7. The Company and the Investor consider that the Founder should receive
adequate compensation for his agreement to work for the company at this stage
and as such, his shareholding should not be materially diluted. As a
precondition of its further financial support, the Investor has required, and
the Company agrees, that the Founder is to receive a total of 8,776 Ordinary
Company Shares at their nominal value (NIS 0.1), to be issued to the Founder as
follows:
Following the execution of the initial Loan Installment the Company shall issue
to the Founder 2926 Ordinary Shares, while promptly following each of the two
ensuing Loan Installments the Company shall issue the Founder 2,925 Ordinary
Shares.

8. The Company and the Investor consider that Dr. Sydney O'hara should receive
adequate compensation for his agreement to consult for the company at this stage
and as such, his shareholding should not be materially diluted. As a
precondition of its further financial support, the Investor has required, and
the Company agrees, that Dr. Sydney O'hara is to receive a total of 605 Ordinary
Shares at their nominal value (NIS 0.1), to be issued to Dr. Sydney O'hara as
follows:

Following the execution of the initial Loan Installment, the Company shall issue
to Dr. Sydney O'hara 203 Ordinary Shares, while promptly following each of the
two ensuing Loan Installments the Company shall issue Dr. Sydney O'hara 201
Ordinary Shares.

                                      -5-
<PAGE>

9. The Company and the Investor consider that ActivePoint employees, officers
and consultants (collectively, "EMPLOYEES") should be adequately remunerated for
continuing to work for the Company at the present stage, and, as a precondition
of its further financial support, the Investor has required, and the Company
agrees, that a total of 1,550 Ordinary Company Shares at their nominal value
(NIS 0.1) shall be issued to M. Porath & Co. Trust Company (1995) Ltd. ("M.
PORATH TRUST CO.") to be held thereby in trust and reserved for issuance to
Employees under a Share Option Plan to be adopted by the Company and Option
Agreements to be signed with the Employees, as follows:

Following the execution of the initial Loan Installment the Company shall issue
to M. Porath Trust Co. 518 Ordinary Shares, while promptly following each of the
two ensuing Loan Installments the Company shall issue M. Porath Trust Co. 516
Ordinary Shares.

10. The execution of this Addendum shall be subject to inter alia, the approval
of the Company's Board of Directors and Shareholders' Meeting. Subject to the
provisions of the Addendum, the Agreement (including all Addendums thereto)
shall remain unaltered.

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly
executed on the date first above
written:
/S/ ONN TAVOR_______________                 /S/ A.SIMON____________
ACTIVEPOINT LTD.                             TOPSCHUTTER HOLDING B.V.

BY:  ONN TAVOR_____________                  BY: A. SIMON___________
     ----------------------                      -------------------

TITLE:  CEO________________                  TITLE: AUTHORIZED SIGNATORY

/S/ ONN TAVOR_______________

                                      -6-EXHIBIT 4.3 - ADDENDUM NO.6 TO INVESTMENT AGREEMENT DATED AUGUST 21, 2002

                                   Addendum #6
               To an Agreement made and entered on 16 January 2000

          Made and entered on this 21 day of August 2002, by and among:

 Activepoint Ltd.
 Company No. 51-0255867-7
 Poleg Industrial Park, Giborei Israel 20, Netanya, Israel, 42504
(Hereinafter: the "COMPANY")

 and

 Onn Tavor
 I.D. 056148745
 of 10 Bet Shammai St., Ramat Hasharon
(Hereinafter the "FOUNDER")

 and

 Topschutter Holding B. V.
 c/o Mr. Jean Paul Croisier, 61 Rue du Rhone
Geneve, Switzerland
 (Hereinafter the "INVESTOR")

 and

 SHIR H.Y.E.R. Holdings Ltd. c/o Dr. Zeev Holender
 40 Montefiori st', Tel Aviv
 (Hereinafter the "SHIR H. Y.E.R.")

WHEREAS, The Company, the Founder and the Investor have previously executed an
Agreement dated January 16, 2000 (the "INVESTMENT AGREEMENT") and an Addendum
thereto dated May 28,2000 (the "FIRST ADDENDUM"), a second Addendum thereto
dated February 01, 2001 (the "SECOND ADDENDUM"), and a third Addendum thereto
dated July 29, 2001 (the "THIRD ADDENDUM"), and a fourth Addendum thereto dated

<PAGE>

December 10, 2001 (the "FOURTH ADDENDUM") and a fifth Addendum thereto dated
June -' 2002 (the "FIFTH ADDENDUM") (the Investment Agreement, and the First,
Second, Third, Fourth and Fifth Addendums shall be hereinafter referred to
jointly as the "AGREEMENT"); and

WHEREAS, the Company, the Founder and the Investor wish to add to and/or amend
the provisions of the Agreement, as set forth hereinafter in this sixth addendum
(the" ADDENDUM"); and

WHEREAS, SHIR H.Y.E.R. is a shareholder of the Company and has previously
invested funds in the Company; and

WHEREAS, SHIR H.Y.E.R. agreed to provide a loan to the Company, as set forth in
this Addendum;

NOW, THEREFORE, in consideration of the premises, mutual agreements and
covenants set forth below, the Parties agree:

1. Unless the context compels otherwise, the terms used in this Addendum shall
bear the meanings ascribed thereto in the Agreement.

2. The Company and the Founder represent that upon completion of the investment
stipulated under the Fifth Addendum by the Investor and the investment
stipulated under the agreement entitled "Addendum 5A" with SHIR HY.E.R., and
prior to the execution of the transaction stipulated herein, and further, prior
to any additional investment or loan undertaken by the Investor and SHIR
H.Y.E.R. with the approval of the Founder as detailed herein, the holdings of
the Company's share capital, on a fully diluted basis, shall be as listed
hereunder (all Company shares bear a par value of NIS 0.1):

                                      -2-
<PAGE>
<TABLE>
<CAPTION>

-------------------------------------------------------------------------------------------------------
  NAME OF SHAREHOLDER                                  HOLDINGS
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
<S>                                                        <C>
  a. The Founder 14,426 Ordinary Shares
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
  b. The Investor                                      2750   Ordinary    Shares;   29,235   Preferred
                                                       Shares.
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
  c. Target Technology Center                             1500 Ordinary Shares (out of which      1000
                                                               are  held   in   trust  for   Company
                                                       shares
                                                       employees, and an additional 125 shares were I
-------------------------------------------------------------------------------------------------------

-------------------------------------------------------------------------------------------------------
                                                       held in trust for Mr. Azriel Kadim, and are to
                                                       be transferred
                                                       thereto).
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
 d. Daniel Eini 250 Ordinary Shares
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
 e. Yitzhak Turkeltaub 250 Ordinary Shares
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
 f. SHIR H.Y.E.R. Holdings Ltd.                        250 Ordinary Shares; 1,639 Preferred Shares
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
 g. Y.E.R.H Trusts Ltd.                                159 Ordinary Shares
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
 h. Dr. Sydney O'Hara                                  986 Ordinary Shares
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
 i. M. Porath & Co. Trust Company (1995)               1,550 Ordinary Shares
 Ltd.
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
 j. Christopher Gare                                   Vested with option to purchase 64 Ordinary
                                                      Shares at par value.
                                                                to     purchase  an   additional   128
                                                       Options
                                                          Ordinary Shares in the aggregate, at     par
                                                       value, will   vest  m    accordance   with  the
                                                          .. of the
                                                      Company's
                                                      agreement
                                                      provisions
                                                      therewith.
-------------------------------------------------------------------------------------------------------
</TABLE>

 Besides the foregoing, there are no additional outstanding Company shares,
 options to purchase shares, or other securities of any kind.

3. In addition to the Investor's previous investments in the Company, the
Investor hereby undertakes to provide a further loan to the Company up to the
amount of $75,000 (seventy five thousand dollars) (the "Investor's Loan")
subject to and pursuant with the provisions hereof. The Investor Loan is
intended to be used by the Company to finance the operations of the Company, and
shall be used consistent with a budget to be prepared by the Company in
conjunction with the Investor's representative (notwithstanding the foregoing,
the Company shall have the overriding right to supervise and oversee the
allocation of the Investor's Loan funds, to have access thereto, and to
determine how they shall be expended, including, inter alia, to determine that a
portion of the funds be utilized for different Company requirements, such as
travel expenditures, etc., subject to the Investor's approval at all times).
 The Investor will convey the Investor's Loan to the Company not later than by
August 30, 2002

                                      -3-
<PAGE>

 4. The Company shall issue the Investor a total of 127,185 Preferred Company
 Shares at their nominal value (NIS 0.1) (CONSEQUENT TO WHICH, UPON COMPLETION
 OF ALL THE SHARE ISSUANCES CONTEMPLATED IN THIS ADDENDUM, THE HOLDINGS OF THE
 INVESTOR IN THE COMPANY SHALL COMPRISE 67.01% OF THE OUTSTANDING SHARE CAPITAL
 OF THE COMPANY, ON A FULLY DILUTED BASIS), which shall be issued thereto
 forthwith upon the execution of the Investor's Loan.

5. In addition to the foregoing, the Investor shall likewise be entitled to
receive the following: Subject to any taxes and mandatory payments imposed on
the Company (such as royalties due to the Israeli chief scientist), 25% of all
amounts, in excess of an initial sum of U.S. $100,000 which is to remain in the
Company, up to a total amount equaling the sums of the loans actually extended
by the Investor under the Fourth Addendum, the Fifth Addendum, and this Sixth
Addendum, i.e. up to a possible TOTAL of U.S. $255,000, a sum comprised of the
nominal sum of the actual total of the Investor's Loan (i.e. up to a potential
total of U.S. $75,000) plus the nominal sums of the loans actually granted to
the Company pursuant to the Fourth Addendum (i.e. U.S.$135,000) and the Fifth
Addendum (i.e. U.S. $45,000), all such sums free of any interest and/or
adjustment of any kind (the "Investor's Loan Repayment"). All such sums accrued
on account of the Investors Loan Repayment shall be transferred to the Investor
immediately (within fourteen (14) working days) upon their actual receipt by the
Company. The Investor shall harbor no claim towards the Founder personally and
the Founder shall have no responsibility or liability whatsoever if the Company
fails to repay the Investor's Loan provided by the Investor hereunder. The
provisions of this Section 5 shall replace the provisions of Section 5 of the
Fifth Addendum.

6. Following execution in full of the Investor's Loan and SHIR H.Y.E.R.'s Loan,
and issuance of all shares to be issued to all parties mentioned herein, all in
accordance with the terms of this Addendum, the holdings of the Company's share
capital, on a fully diluted basis, shall be as listed in the "cap table"
"Appendix B" hereto. 7. In addition to SHIR H.Y.E.R.'s previous investments in
the Company, SHIR H.Y.E.R. hereby undertakes to provide a further loan to the
Company up to the amount of $3,874 (three thousand, eight hundred and
seventy-four dollars) (the "SHIR H.Y.E.R.'S LOAN") subject to and pursuant with
the provisions hereof. SHIR H.Y.E.R.'s Loan is intended to be used by the
Company to finance the operations of the Company, and shall be used consistent
with a budget to be prepared by the Company in conjunction with SHIR H.Y.E.R.'s
representative (notwithstanding the foregoing, the Company shall have the
overriding right

                                      -4-
<PAGE>

 to supervise and oversee the allocation of the SHIR H.Y.E.R.'s Loan funds, to
 have access thereto, and to determine how they shall be expended, including,
 inter alia, to determine that a portion of the funds be utilized for different
 Company requirements, such as travel expenditures, etc., subject to SHIR
 H.Y.E.R.'s approval at all times).

 SHIR H.Y.E.R. will convey the SHIR H.Y.E.R.'s Loan to the Company not later
 than by August 30,2002. 8. The Company shall issue SHIR H.Y.E.R.'s a total of
 6,570 Preferred Company Shares at their nominal value (NIS 0.1) (CONSEQUENT TO
 WHICH, UPON COMPLETION OF ALL THE SHARE ISSUANCES CONTEMPLATED IN THIS
 ADDENDUM. THE HOLDINGS OF SHIR H.Y.E.R.. IN THE COMPANY SHALL COMPRISE 3.56% OF
 THE OUTSTANDING SHARE CAPITAL OF THE COMPANY, ON A FULLY DILUTED BASIS), which
 shall be issued thereto forthwith upon the execution of SHIR H.Y.E.R.'s Loan.

9. In addition to the foregoing, SHIR H.Y.E.R. shall likewise be entitled to
 receive the following: Subject to any taxes and mandatory payments imposed on
 the Company (such as royalties due to the Israeli chief scientist), 25% of all
 amounts, in excess of an initial sum of U.S. $100,000 which is to remain in the
 Company, up to a total amount equaling the sums of the loans actually extended
 by SHIR H.Y.E.R.'s under Addendum 4A and 5A signed between the Company and SHIR
 H.Y.E.R., and this Sixth Addendum, i.e. up to a possible total of U.S. $21,400,
 a sum comprised of the nominal sum of the actual total of the SHIR H.Y.E.R.'s
 Loan (i.e. up to a potential total of U.S. $3,874) plus the nominal sums of the
 loans actually granted to the Company pursuant to Addendum 4A (i.e.
 U.S.$15,000) and Addendum 5A (i.e. U.S. $2,526), all such sums free of any
 interest and/or adjustment of any kind (the "SHIR H.Y.E.R.'S LOAN REPAYMENT").
 All such sums accrued on account of SHIR H.Y.E.R.'s Loan Repayment shall be
 transferred to SHIR H.Y.E.R. immediately (within fourteen (14) working days)
 upon their actual receipt by the Company. SHIR H.Y.E.R. shall harbor no claim
 towards the Founder personally and the Founder shall have no responsibility or
 liability whatsoever if the Company fails to repay SHIR H.Y.E.R.'s Loan
 provided by SHIR H.Y.E.R. hereunder. The provisions of this Section 9 shall
 replace the provisions of Section 5 of Addendum 5A.

10. In the event that at any time prior to the full repayment of the above
loans, the Company will not have sufficient funds to allow full repayment of
both the Investor's Loan and SHIR H.Y.E.R.'s Loan in accordance with Sections 5
and 9 above, repayment will be made by the Company to both said lenders, out of
the available amounts in excess of an initial sum of U.S. $100,000, pro rata to
the Company's outstanding debt to each of them at such time.

                                      -5-
<PAGE>

 11. The Company and the Investor consider that the Founder should receive
 adequate compensation for his agreement to work for the company at this stage,
 and as such, his shareholding should not be materially diluted. As a
 precondition of its further financial support, the Investor has required, and
 the Company agrees that, the Founder is to receive a total of 45,010 Ordinary
 Company Shares at their nominal value (NIS 0.1) (CONSEQUENT TO WHICH, UPON
 COMPLETION OF ALL THE SHARE ISSUANCES CONTEMPLATED IN THIS ADDENDUM, THE
 HOLDINGS OF THE FOUNDER IN THE COMPANY SHALL COMPRISE 25.02% OF THE OUTSTANDING
 SHARE CAPITAL OF THE COMPANY, ON A FULLY DILUTED BASIS)" to be issued to the
 Founder following the execution of the Investor's Loan and SHIR H.Y.E.R.'s
 Loan. 12. The Company and the Investor consider that Dr. Sydney O'hara should
 receive adequate compensation for his agreement to consult for the company at
 this stage, and as such, the Company should accord him additional Company
 shares for his ongoing significant efforts and contributions to the Company. As
 a precondition of its further financial support, the Investor has required, and
 the Company agrees, that Dr. Sydney O'hara is to receive a total of 5,695
 Ordinary Company Shares at their nominal value (NIS 0.1) (CONSEQUENT TO WHICH,
 UPON COMPLETION OF ALL THE SHARE ISSUANCES CONTEMPLATED IN THIS ADDENDUM, THE
 HOLDINGS OF DR. 0'HARA IN THE COMPANY SHALL COMPRISE 2.81% OF THE OUTSTANDING
 SHARE CAPITAL OF THE COMPANY, ON A FULLY DILUTED BASIS)" to be issued to Dr.
 Sydney O'hara following the execution of the Investor's Loan and SHIR
 H.Y.E.R.'s Loan. 13. The execution of this Addendum shall be subject to, inter
 alia, the approval of the Company's Board of Directors and Shareholders'
 Meeting. Subject to the provisions of this Addendum, the Agreement (including
 all Addendums thereto) shall remain unaltered.
 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly
 executed on the date first above written:

 /S/ ONN TAVOR_______                 /S/ A. B. SIITOM_________
 --------------------                 -------------------------
 ACTIVEPOINT LTD.                     TOPSCHUTTER HOLDING B.V.

 BY:  ONN TAVOR_____                  BY: A.B. SIITOM________
      --------------                      -------------------

 TITLE: CEO________                   TITLE:  AUTHORIZED SIGNATORY

 /S/ ONN TAVOR______                  ______________________
 -------------------
                                      SHIR H.Y.E.R. HOLDINGS LTD.

                                      BY:  ___________________

                                      TITLE: _________________

                                      -6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]